DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Developmental tumors in children and young adults carry few genetic alterations, yet they have diverse clinical presentation. Focusing on Ewing sarcoma, we sought to establish the prevalence and characteristics of epigenetic heterogeneity in genetically homogeneous cancers. We performed genome-scale DNA methylation sequencing for a large cohort of Ewing sarcoma tumors and analyzed epigenetic heterogeneity on three levels: between cancers, between tumors, and within tumors. We observed consistent DNA hypomethylation at enhancers regulated by the disease-defining EWS-FLI1 fusion protein, thus establishing epigenomic enhancer reprogramming as a ubiquitous and characteristic feature of Ewing sarcoma. DNA methylation differences between tumors identified a continuous disease spectrum underlying Ewing sarcoma, which reflected the strength of an EWS-FLI1 regulatory signature and a continuum between mesenchymal and stem cell signatures. There was substantial epigenetic heterogeneity within tumors, particularly in patients with metastatic disease. In summary, our study provides a comprehensive assessment of epigenetic heterogeneity in Ewing sarcoma and thereby highlights the importance of considering nongenetic aspects of tumor heterogeneity in the context of cancer biology and personalized medicine..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Nature medicine - 23(2017), 3, Seite 386 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sheffield, Nathan C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer cells |
|---|
| doi: |
10.1038/nm.4273 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1993439854 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1993439854 | ||
| 003 | DE-627 | ||
| 005 | 20230715050227.0 | ||
| 007 | tu | ||
| 008 | 170512s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nm.4273 |2 doi | |
| 028 | 5 | 2 | |a PQ20170501 |
| 035 | |a (DE-627)OLC1993439854 | ||
| 035 | |a (DE-599)GBVOLC1993439854 | ||
| 035 | |a (PRQ)c2020-f428a44f3a62db43164001baec49d2d8475f449ea0d818e9dd3a0fb0478556950 | ||
| 035 | |a (KEY)0272729320170000023000300386dnamethylationheterogeneitydefinesadiseasespectrum | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Sheffield, Nathan C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Developmental tumors in children and young adults carry few genetic alterations, yet they have diverse clinical presentation. Focusing on Ewing sarcoma, we sought to establish the prevalence and characteristics of epigenetic heterogeneity in genetically homogeneous cancers. We performed genome-scale DNA methylation sequencing for a large cohort of Ewing sarcoma tumors and analyzed epigenetic heterogeneity on three levels: between cancers, between tumors, and within tumors. We observed consistent DNA hypomethylation at enhancers regulated by the disease-defining EWS-FLI1 fusion protein, thus establishing epigenomic enhancer reprogramming as a ubiquitous and characteristic feature of Ewing sarcoma. DNA methylation differences between tumors identified a continuous disease spectrum underlying Ewing sarcoma, which reflected the strength of an EWS-FLI1 regulatory signature and a continuum between mesenchymal and stem cell signatures. There was substantial epigenetic heterogeneity within tumors, particularly in patients with metastatic disease. In summary, our study provides a comprehensive assessment of epigenetic heterogeneity in Ewing sarcoma and thereby highlights the importance of considering nongenetic aspects of tumor heterogeneity in the context of cancer biology and personalized medicine. | ||
| 650 | 4 | |a Cancer cells | |
| 650 | 4 | |a Ewing's sarcoma | |
| 650 | 4 | |a Methylation | |
| 650 | 4 | |a Health aspects | |
| 650 | 4 | |a Genetic aspects | |
| 700 | 1 | |a Pierron, Gaelle |4 oth | |
| 700 | 1 | |a Klughammer, Johanna |4 oth | |
| 700 | 1 | |a Datlinger, Paul |4 oth | |
| 700 | 1 | |a Schonegger, Andreas |4 oth | |
| 700 | 1 | |a Schuster, Michael |4 oth | |
| 700 | 1 | |a Hadler, Johanna |4 oth | |
| 700 | 1 | |a Surdez, Didier |4 oth | |
| 700 | 1 | |a Guillemot, Delphine |4 oth | |
| 700 | 1 | |a Lapouble, Eve |4 oth | |
| 700 | 1 | |a Freneaux, Paul |4 oth | |
| 700 | 1 | |a Champigneulle, Jacqueline |4 oth | |
| 700 | 1 | |a Bouvier, Raymonde |4 oth | |
| 700 | 1 | |a Walder, Diana |4 oth | |
| 700 | 1 | |a Ambros, Ingeborg M |4 oth | |
| 700 | 1 | |a Hutter, Caroline |4 oth | |
| 700 | 1 | |a Sorz, Eva |4 oth | |
| 700 | 1 | |a Amaral, Ana T |4 oth | |
| 700 | 1 | |a de Alava, Enrique |4 oth | |
| 700 | 1 | |a Schallmoser, Katharina |4 oth | |
| 700 | 1 | |a Strunk, Dirk |4 oth | |
| 700 | 1 | |a Rinner, Beate |4 oth | |
| 700 | 1 | |a Liegl-Atzwanger, Bernadette |4 oth | |
| 700 | 1 | |a Huppertz, Berthold |4 oth | |
| 700 | 1 | |a Leithner, Andreas |4 oth | |
| 700 | 1 | |a de Pinieux, Gonzague |4 oth | |
| 700 | 1 | |a Terrier, Philippe |4 oth | |
| 700 | 1 | |a Laurence, Valerie |4 oth | |
| 700 | 1 | |a Michon, Jean |4 oth | |
| 700 | 1 | |a Ladenstein, Ruth |4 oth | |
| 700 | 1 | |a Holter, Wolfgang |4 oth | |
| 700 | 1 | |a Windhager, Reinhard |4 oth | |
| 700 | 1 | |a Dirksen, Uta |4 oth | |
| 700 | 1 | |a Ambros, Peter F |4 oth | |
| 700 | 1 | |a Delattre, Olivier |4 oth | |
| 700 | 1 | |a Kovar, Heinrich |4 oth | |
| 700 | 1 | |a Bock, Christoph |4 oth | |
| 700 | 1 | |a Tomazou, Eleni M |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d New York, NY : Nature Publ. Co., 1995 |g 23(2017), 3, Seite 386 |w (DE-627)182598845 |w (DE-600)1220066-9 |w (DE-576)044282524 |x 1078-8956 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2017 |g number:3 |g pages:386 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1038/nm.4273 |3 Volltext |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1875119848 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_168 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2120 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2017 |e 3 |h 386 | ||